Who owns LIPOCINE INC NEW?
- Ticker: LPCN
- CUSIP Number: 53630x203
Tip: Access positions for across all investors
Analyze quarterly positions in Lipocine with up to 7 years of data, all consolidated into one spreadsheet
Download as csvTop investors of Lipocine stock
Who bought or sold LIPOCINE INC NEW this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Diadema Partners | 261k | $2.1M | 100% | Dec 2025 |
|
| Vanguard Group | 222k | $1.8M | 0% | Dec 2025 |
|
| Ikarian Capital | 200k | $1.6M | 100% | Dec 2025 |
|
| BlackRock | 89k | $717k | 0% | Dec 2025 |
|
| Persistent Asset Partners | 71k | $567k | 100% | Dec 2025 |
|
| Geode Capital Management | 63k | $502k | 2% | Dec 2025 |
|
| Boothbay Fund Management | 55k | $441k | 100% | Dec 2025 |
|
| Renaissance Technologies | 37k | $300k | 4% | Dec 2025 |
|
| Susquehanna International | 25k | $200k | -47% | Dec 2025 |
|
| State Street Corporation | 19k | $150k | 0% | Dec 2025 |
|
| Ameriprise Financial | 16k | $129k | 100% | Dec 2025 |
|
| Citadel Advisors | 14k | $41k | 100% | Sep 2025 |
|
| Northern Trust | 13k | $106k | 0% | Dec 2025 |
|
| Dimensional Fund Advisors | 12k | $98k | 0% | Dec 2025 |
|
| Jane Street | 11k | $85k | 100% | Dec 2025 |
|
| UBS Group | 5.6k | $45k | 217% | Dec 2025 |
|
| Caldwell Sutter Capital | 471.00 | $3.8k | 0% | Dec 2025 |
|
| Group One Trading | 162.00 | $1.3k | 0% | Dec 2025 |
|
| Advisor Group Holdings | 118.00 | $946.997200 | -95% | Dec 2025 |
|
| HighMark Wealth Management | 100.00 | $803.000000 | 100% | Dec 2025 |
|
| SBI Securities | 67.00 | $538.003300 | 0% | Dec 2025 |
|
| Tidemark | 59.00 | $474.000100 | 0% | Dec 2025 |
|
| FMR | 59.00 | $168.999600 | 100% | Sep 2025 |
|
| Royal Bank of Canada | 1.00 | $0 | 100% | Sep 2025 |
|
Who sold out of Lipocine?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Barclays | Sep 2025 | 9.4k | $27k |
| Tower Research Capital | Sep 2025 | 1.2k | $3.3k |